Everest Medicines announces acceptance of Velsipity NDA in Hong Kong to treat moderately to severely active ulcerative ...
Everest Medicines, a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, announced that Department of Health of the Government of the Hong Kong Special Administrative …